Introduction Malignant pleural effusion (MPE) affects up to 15% of patients with cancer, and its incidence and prevalence are increasing. 1 - 4 Most cases are symptomatic; the most common symptoms are ...
DelveInsight's“ Malignant Pleural Effusion Pipeline Insight” report provides comprehensive global coverage of pipeline therapies for Malignant Pleural Effusion across various stages of clinical ...
A phase I/II, open label trial of Lewis Y specific monoclonal antibody IGN311 to evaluate safety and efficacy in patients with malignant effusion This is an ASCO Meeting Abstract from the 2006 ASCO ...
Please provide your email address to receive an email when new articles are posted on . The average health care cost per patient in the indwelling pleural catheter (IPC) group was $40,179 vs. $46,640 ...
Identifying and analyzing volatile organic compounds in exhaled breath of patients with malignant pleural mesothelioma showed promise as a screening method for MPM, according to research presented ...
New microfluidic device improves the separation of tumor cells and clusters from malignant effusions
Researchers have unveiled a microfluidic device that significantly improves the separation of tumor cells and clusters from malignant effusions. This novel technology promises to advance the diagnosis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results